Category Archives: Healthcare

A Director at KalVista Pharmaceuticals Inc (NASDAQ: KALV) is Buying Shares

Today, a Director at KalVista Pharmaceuticals Inc (KALV – Research Report), Albert Cha, bought shares of KALV for $1.09M. Following this transaction Albert Cha’s holding in the company was increased by 14.46% to a total of $24.93 million. Following Albert

William Blair Reiterates a Buy Rating on Seattle Genetics (SGEN)

In a report issued on July 17, Andy Hsieh from William Blair reiterated a Buy rating on Seattle Genetics (SGEN – Research Report). The company’s shares opened today at $76.13. According to TipRanks.com, Hsieh is a 2-star analyst with an

Raymond James Reaffirms Their Buy Rating on Knight Therapeutics (GUD)

Knight Therapeutics (GUD – Research Report), the Healthcare company was revisited today, and remains undervalued for at least one analyst on the street. Analyst David Novak from Raymond James reiterated a Buy rating, with a C$10.25 price target. According to

Analysts Are Bullish on These Healthcare Stocks: Titan Medical Inc (TMDI), Clearside Biomedical (CLSD)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Titan Medical Inc (TMDI – Research Report) and Clearside Biomedical (CLSD – Research Report) with bullish sentiments. Titan Medical Inc (TMDI) In

H.C. Wainwright Thinks Melinta Therapeutics Inc’s Stock is Going to Recover

In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Melinta Therapeutics Inc (MLNT – Research Report), with a price target of $13. The company’s shares closed yesterday at $3.75, close to its 52-week low

Cowen & Co. Keeps a Buy Rating on Esperion (ESPR)

Cowen & Co. analyst Chris Shibutani maintained a Buy rating on Esperion (ESPR – Research Report) today and set a price target of $80. The company’s shares closed yesterday at $43.78. According to TipRanks.com, Shibutani is a 4-star analyst with